SciSight Ecosystem
WoS SCIE Q2Scopus Q1SCImago #6,328CAS 3区Review JournalHybrid

Expert Review of Clinical Pharmacology

Abbreviation (ISO):Expert Rev. Clin. Pharmacol
Country: England•WoS SCIE Quartile: Q2•Scopus SJR: 0.848•SCImago Rank: #6,328•Identifier (ISSN):1751-2433(Print)/1751-2441(Online)•Articles / Year: 112•Estimated Publication Fee (APC): $3,292 USD
Clarivate IF (2026)Q2
3.6
↑ +0.6

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
32

32 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate2.8%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
112articles/year
4.09% Gold OA•33.59% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

1.75pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q2 có IF ≥ 2.0(IF: 3.6)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20261.75đ
WoS Q2 có IF ≥ 2.0(IF: 3.6)
🔵 Computed
20251.75đ
WoS Q2 có IF ≥ 2.0(IF: 3)
🔵 Computed
20241.75đ
WoS Q2 có IF ≥ 2.0(IF: 3.6)
🔵 Computed
20231.75đ
WoS Q2 có IF ≥ 2.0(IF: 4.4)
🔵 Computed
20221.75đ
WoS Q2 có IF ≥ 2.0(IF: 4.108)
🔵 Computed
20211.75đ
WoS Q2 có IF ≥ 2.0(IF: 5.045)
🔵 Computed
20201.75đ
WoS Q2 có IF ≥ 2.0(IF: 3.481)
🔵 Computed
20191.75đ
WoS Q2 có IF ≥ 2.0(IF: 2.776)
🔵 Computed
20181.75đ
WoS Q2 có IF ≥ 2.0(IF: 2.758)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

Advances in drug development technologies are yielding innovative new therapies, from potentially lifesaving medicines to lifestyle products. In recent years, however, the cost of developing new drugs has soared, and concerns over drug resistance and pharmacoeconomics have come to the fore. Adverse reactions experienced at the clinical trial level serve as a constant reminder of the importance of rigorous safety and toxicity testing. Furthermore the advent of pharmacogenomics and ‘individualized’ approaches to therapy will demand a fresh approach to drug evaluation and healthcare delivery. Clinical Pharmacology provides an essential role in integrating the expertise of all of the specialists and players who are active in meeting such challenges in modern biomedical practice.

Topics Covered (Recognized by AI)
Medicine99.9%Biology96%Internal medicine84.1%Pharmacology65.3%Pathology57.4%Genetics51.7%Chemistry49.7%Psychology46%Biochemistry43.6%Psychiatry41.6%Bioinformatics40.1%Intensive care medicine38.5%Endocrinology31.4%Immunology29.3%Surgery29%Clinical trial21.2%Disease21%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #6,328Scopus Q1SCImago Profile
Scopus Coverage:2008-2026
Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q1
0.848

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q1
Scopus H-Index (2025)
73

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
3.19

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,292 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations1,144
3-Year Documents343
Citable Documents305

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate44.7%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmacology, Toxicology and Pharmaceutics (miscellaneous)Q1
Medicine (miscellaneous)Q2
Pharmacology (medical)Q2

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区PHARMACOLOGY & PHARMACY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Taylor and Francis Ltd.
Publication Language
English
Frequency
Periodic
Editorial Address
2-4 PARK SQUARE, MILTON PARK, ABINGDON, England, OXON, OX14 4RN
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
PHARMACOLOGY & PHARMACY
JCRSCIE
128/356Q2
PHARMACOLOGY & PHARMACY
JCISCIE
191/356Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—7423
2025395252
20243.6103670
20234.41151,193
20224.1081321,677
20215.0451283,164
20203.4811303,055
20192.7761143,498
20182.7581104,353
2017—1233,630
2016—1373,377
2015—1092,917
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Expert Review of Clinical Pharmacology

WoS Q2
1346201820192020202120222023202420253.00
Annual Impact Factor Metric
2025:3

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 2.8%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: edd723ab-12ec-442d-a312-eadec8f5495f
Database Updated: 2026-09-30